An in-depth look at pharmacy and medical drug trends is available in the 2021 IngenioRx Drug Trend Report. For our pharmacy benefit manager, IngenioRx, 2021 was a year of continued growth, change, and accomplishments. Look behind the numbers to see what drove pharmacy spend last year.
In 2021, medical and pharmacy overall drug spend was primarily driven by utilization, inflation, and the arrival of new drugs on the market. Despite those influences, IngenioRx kept trends in the low-single digits, and even in the negative on nonspecialty:
- 3.6% Overall trend Medical and Pharmacy
- -1.7% Nonspecialty
- 7.1% Specialty Medical and Pharmacy
How did IngenioRx do it? Trend mitigation strategies
Last year, IngenioRx launched new clinical programs that resulted in an estimated $750 million in incremental savings. These trend mitigation strategies included, but not limited to:
- Evidence-based formularies and clinical edits.
- High-touch member outreach.
- Cost-management strategies.
- Utilization and channel management.
- Pharmacists partnering with providers.
Read the full report to learn more about what IngenioRx does to keep drug spend down for your clients and your client’s employees.